Analyst Expectations For Insulet's Future
Portfolio Pulse from Benzinga Insights
Insulet (NASDAQ:PODD) has been analyzed by five analysts, showing a range of opinions from bullish to bearish. Recent analyst actions include raising and lowering price targets, with an average 12-month target of $242.4, up 5.85% from the previous $229. Insulet's financial performance is strong, with high revenue growth, net margin, ROE, and ROA, but it faces challenges with a high debt-to-equity ratio.
September 17, 2024 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Insulet has received mixed analyst ratings, with a recent increase in the average price target to $242.4, indicating positive sentiment. The company's strong financial performance is highlighted by high revenue growth and profitability, but it faces challenges with a high debt-to-equity ratio.
The increase in the average price target suggests positive sentiment among analysts, which could lead to a short-term price increase. Insulet's strong financial metrics, such as high revenue growth and profitability, support this positive outlook. However, the high debt-to-equity ratio is a concern that could limit the upside potential.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100